NCT05328297: A reported trial by Janssen Pharmaceutica N.V., Belgium
This trial has reported on time, in line with the regulations.
Full data
| Full entry on ClinicalTrials.gov | NCT05328297 |
|---|---|
| Title | A Randomized, Stratified, Double-blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of JNJ-55308942 in Bipolar Depression |
| Results Status | Reported |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | June 3, 2022 |
| Completion date | May 17, 2024 |
| Required reporting date | May 17, 2025, midnight |
| Actual reporting date | May 14, 2025 |
| Date last checked at ClinicalTrials.gov | Dec. 3, 2025 |
| Days late | None |